Profile
Stephen Lichaw is currently the Vice President-Business Development at Lirum Therapeutics, Inc. He previously worked as a Managing Director at Middlebury Securities LLC and as a Principal at Ladenburg Thalmann & Co., Inc. Mr. Lichaw holds an MBA from Cornell University and an undergraduate degree from the University of Hartford.
Stephen Lichaw active positions
| Companies | Position | Start |
|---|---|---|
| LIRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 2022-07-31 |
Former positions of Stephen Lichaw
| Companies | Position | End |
|---|---|---|
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Corporate Officer/Principal | - |
Middlebury Securities LLC
Middlebury Securities LLC Investment ManagersFinance Middlebury Securities invests in companies located in the United States. The firm focuses on life sciences sector. The firm participates in early stage capital funding and lending of structured debt. | Private Equity Investor | - |
Training of Stephen Lichaw
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hartford
University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Finance |
Middlebury Securities LLC
Middlebury Securities LLC Investment ManagersFinance Middlebury Securities invests in companies located in the United States. The firm focuses on life sciences sector. The firm participates in early stage capital funding and lending of structured debt. | Finance |
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
- Stock Market
- Insiders
- Stephen Lichaw
















